Plasma E-selectin levels can play a role in the development of diabetic retinopathy

Márta Kasza, J. Meleg, J. Vardai, B. Nagy, E. Szalai, J. Damjanovich, A. Csutak, B. Ujhelyi, V. Nagy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Diabetic retinopathy is one of the leading causes of blindness. There are several risk factors, such as the duration of diabetes or glycemic control of the patient; however, several biochemical factors also alter the process. Our aim was to investigate the role of soluble E-selectin in the formation of diabetic retinopathy. Patients and methods: Fifty-seven patients (37 female and 20 male, aged 61.71 ± 12.31 years) and 14 healthy control subjects (ten female and four male, aged 63.06 ± 10.46 years) were enrolled in the study. We measured the soluble E-selectin level in the plasma of patients by ELISA. All patients underwent careful ophthalmological examination, including ophthalmoscopy and color fundus photography, while diabetic retinopathy grading was performed in line with the 2012 classification of the American Academy of Ophthalmology (AAO). Results: The soluble E-selectin level was significantly higher in patients with diabetes compared to controls (32.95 ng/ml vs. 26.55 ng/ml, p = 0.03). Dividing patients into groups by the presence of retinopathy, the E-selectin level was also significantly higher in the retinopathy group (p <0.05). When we examined diabetic patients by the severity of retinopathy (groups A, B, and C, by the guidelines of the AAO), however, we did not find any significant difference in soluble E-selectin levels, although it tended to be higher in group B. Conclusions: An elevated E-selectin level can play a role in the development of diabetic retinopathy, but it does not seem to alter disease severity. However, glycemic control and the reduction of cardiovascular risk factors may also alter the level of E-selectin that might play a role in the prevention of diabetic retinopathy.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
DOIs
Publication statusAccepted/In press - Jul 4 2016

Fingerprint

E-Selectin
Diabetic Retinopathy
Ophthalmoscopy
Photography
Ophthalmology
Blindness
Healthy Volunteers
Color
Enzyme-Linked Immunosorbent Assay
Guidelines

Keywords

  • Diabetes mellitus
  • Diabetic retinopathy
  • Soluble E-selectin

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Plasma E-selectin levels can play a role in the development of diabetic retinopathy. / Kasza, Márta; Meleg, J.; Vardai, J.; Nagy, B.; Szalai, E.; Damjanovich, J.; Csutak, A.; Ujhelyi, B.; Nagy, V.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, 04.07.2016, p. 1-6.

Research output: Contribution to journalArticle

Kasza, Márta ; Meleg, J. ; Vardai, J. ; Nagy, B. ; Szalai, E. ; Damjanovich, J. ; Csutak, A. ; Ujhelyi, B. ; Nagy, V. / Plasma E-selectin levels can play a role in the development of diabetic retinopathy. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2016 ; pp. 1-6.
@article{458d2b57f1814b538d206358acc607e8,
title = "Plasma E-selectin levels can play a role in the development of diabetic retinopathy",
abstract = "Purpose: Diabetic retinopathy is one of the leading causes of blindness. There are several risk factors, such as the duration of diabetes or glycemic control of the patient; however, several biochemical factors also alter the process. Our aim was to investigate the role of soluble E-selectin in the formation of diabetic retinopathy. Patients and methods: Fifty-seven patients (37 female and 20 male, aged 61.71 ± 12.31 years) and 14 healthy control subjects (ten female and four male, aged 63.06 ± 10.46 years) were enrolled in the study. We measured the soluble E-selectin level in the plasma of patients by ELISA. All patients underwent careful ophthalmological examination, including ophthalmoscopy and color fundus photography, while diabetic retinopathy grading was performed in line with the 2012 classification of the American Academy of Ophthalmology (AAO). Results: The soluble E-selectin level was significantly higher in patients with diabetes compared to controls (32.95 ng/ml vs. 26.55 ng/ml, p = 0.03). Dividing patients into groups by the presence of retinopathy, the E-selectin level was also significantly higher in the retinopathy group (p <0.05). When we examined diabetic patients by the severity of retinopathy (groups A, B, and C, by the guidelines of the AAO), however, we did not find any significant difference in soluble E-selectin levels, although it tended to be higher in group B. Conclusions: An elevated E-selectin level can play a role in the development of diabetic retinopathy, but it does not seem to alter disease severity. However, glycemic control and the reduction of cardiovascular risk factors may also alter the level of E-selectin that might play a role in the prevention of diabetic retinopathy.",
keywords = "Diabetes mellitus, Diabetic retinopathy, Soluble E-selectin",
author = "M{\'a}rta Kasza and J. Meleg and J. Vardai and B. Nagy and E. Szalai and J. Damjanovich and A. Csutak and B. Ujhelyi and V. Nagy",
year = "2016",
month = "7",
day = "4",
doi = "10.1007/s00417-016-3411-1",
language = "English",
pages = "1--6",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Plasma E-selectin levels can play a role in the development of diabetic retinopathy

AU - Kasza, Márta

AU - Meleg, J.

AU - Vardai, J.

AU - Nagy, B.

AU - Szalai, E.

AU - Damjanovich, J.

AU - Csutak, A.

AU - Ujhelyi, B.

AU - Nagy, V.

PY - 2016/7/4

Y1 - 2016/7/4

N2 - Purpose: Diabetic retinopathy is one of the leading causes of blindness. There are several risk factors, such as the duration of diabetes or glycemic control of the patient; however, several biochemical factors also alter the process. Our aim was to investigate the role of soluble E-selectin in the formation of diabetic retinopathy. Patients and methods: Fifty-seven patients (37 female and 20 male, aged 61.71 ± 12.31 years) and 14 healthy control subjects (ten female and four male, aged 63.06 ± 10.46 years) were enrolled in the study. We measured the soluble E-selectin level in the plasma of patients by ELISA. All patients underwent careful ophthalmological examination, including ophthalmoscopy and color fundus photography, while diabetic retinopathy grading was performed in line with the 2012 classification of the American Academy of Ophthalmology (AAO). Results: The soluble E-selectin level was significantly higher in patients with diabetes compared to controls (32.95 ng/ml vs. 26.55 ng/ml, p = 0.03). Dividing patients into groups by the presence of retinopathy, the E-selectin level was also significantly higher in the retinopathy group (p <0.05). When we examined diabetic patients by the severity of retinopathy (groups A, B, and C, by the guidelines of the AAO), however, we did not find any significant difference in soluble E-selectin levels, although it tended to be higher in group B. Conclusions: An elevated E-selectin level can play a role in the development of diabetic retinopathy, but it does not seem to alter disease severity. However, glycemic control and the reduction of cardiovascular risk factors may also alter the level of E-selectin that might play a role in the prevention of diabetic retinopathy.

AB - Purpose: Diabetic retinopathy is one of the leading causes of blindness. There are several risk factors, such as the duration of diabetes or glycemic control of the patient; however, several biochemical factors also alter the process. Our aim was to investigate the role of soluble E-selectin in the formation of diabetic retinopathy. Patients and methods: Fifty-seven patients (37 female and 20 male, aged 61.71 ± 12.31 years) and 14 healthy control subjects (ten female and four male, aged 63.06 ± 10.46 years) were enrolled in the study. We measured the soluble E-selectin level in the plasma of patients by ELISA. All patients underwent careful ophthalmological examination, including ophthalmoscopy and color fundus photography, while diabetic retinopathy grading was performed in line with the 2012 classification of the American Academy of Ophthalmology (AAO). Results: The soluble E-selectin level was significantly higher in patients with diabetes compared to controls (32.95 ng/ml vs. 26.55 ng/ml, p = 0.03). Dividing patients into groups by the presence of retinopathy, the E-selectin level was also significantly higher in the retinopathy group (p <0.05). When we examined diabetic patients by the severity of retinopathy (groups A, B, and C, by the guidelines of the AAO), however, we did not find any significant difference in soluble E-selectin levels, although it tended to be higher in group B. Conclusions: An elevated E-selectin level can play a role in the development of diabetic retinopathy, but it does not seem to alter disease severity. However, glycemic control and the reduction of cardiovascular risk factors may also alter the level of E-selectin that might play a role in the prevention of diabetic retinopathy.

KW - Diabetes mellitus

KW - Diabetic retinopathy

KW - Soluble E-selectin

UR - http://www.scopus.com/inward/record.url?scp=84976897228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976897228&partnerID=8YFLogxK

U2 - 10.1007/s00417-016-3411-1

DO - 10.1007/s00417-016-3411-1

M3 - Article

C2 - 27377657

AN - SCOPUS:84976897228

SP - 1

EP - 6

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

ER -